Predictors of early postpartum vitamin use among women of Mexican origin: Implications for healthcare provider recommendations

Ethnicity and Disease

Volumn 16, Issue 1, 2006, Pages 194-200

  O'Rourke, Kathleen M ^a,d   Roddy, Mary E ^a   Williams, Darryl ^c   Mena, Kristina ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d Lawton Rhea Chiles Center   (United States)

Author keywords

Folic acid; Mexican Americans; Neural tube defects; Postpartum care; Preconception; Vitamin use

Indexed keywords

VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HISPANIC; HUMAN; HUMAN EXPERIMENT; NEURAL TUBE DEFECT; PUERPERIUM; UNITED STATES; VITAMIN SUPPLEMENTATION; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; RISK;

ADULT; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; MEXICAN AMERICANS; NEURAL TUBE DEFECTS; ODDS RATIO; POSTPARTUM PERIOD; TEXAS; VITAMINS;

EID: 33744992698     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Czeizel A, Didas I. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplement. N Engl J Med. 1992;372(26):1832-1835.
2. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of the neural tube defects. JAMA. 1989;262:2847-2852.
3. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260:3141-3145.
4. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and the risk of occurrent neural tube defects. JAMA. 1993;269:1257-1261.
5. MRC. Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study Lancet. 1991;338:131-137.
6. Berry R, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med. 1999;341:1485.
7. Werler M, et al. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150:675-682.
8. Mills J, et al. Methylenetrahydrofolate reductase thermolabile variant and oral clefs. Am J Med Genet. 1999;86:71.
9. Kapusta L, et al. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr. 1999;135:773.
10. James SJ, Pogribna M, Pogrobny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999;70:495-501.
11. Mills JL, Conley MR. Folic acid to prevent neural tube defects: scientific advances and public health issues. Curr Opin Obstet Gynecol. 1996;8(6):394-397.
12. Ubbink JB. Is an elevated circulating maternal homocysteine concentration a risk factor for neural tube defects? Nutr Rev. 1995;53(6): 173-175.
13. CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly Rep. 1992;41(RR-14)
14. March of Dimes. Folic Acid and the Prevention of Birth Defects: A National Survey of Pre-pregnancy Awareness and Behavior Among Women of Childbearing Age, 1995-2003. Conducted by the Gallup Organization. White Plains, NY: March of Dimes; August 2003. Publication No. 31-1784-03.
15. Life Sciences Research Office. Assessment of the Folate Nutritional Status of the US Population Based on Data Collected in the Second National Health and Nutritional Examination Survey, 1976-1980. Bethesda, Md: Federation of American Societies for Experimental Biology; 1984.
16. Ahluwalia IB, Daniel KL. Are women with recent live births aware of the benefits of folic acid? MMWR Recomm Rep. 2001;50(RR06):3-14.
17. Martin JA, Hamilton BG, Ventura SJ, Menacker F, Park MM. Births: final data for 2000. National Vital Statistics Reports. 2002;50(5):1-102. Available at: www.cdc.gov. Accessed on: 9/1/04.
18. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30:24-29.
19. Shaw G, Velie E, Wasserman C. Risk for neural tube defect-affected pregnancies among women of Mexican descent and White women in California. Am J Public Health. 1997;87:1467-1471.
20. CDC. Neural tube defect surveillance and folic acid intervention - Texas-Mexico border, 1993-1998. Morb Mortal Wkly Rep. 2000;49(01):1-4.
21. Giachello A. Maternal/perinatal health. In: Molina C, Aguirre M, eds. In: Latino Health in the US: A Growing Challenge. Washington, DC: American Public Health Association; 1994: 135-187.
22. Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol. 2000;152(11):1017-1023.
23. Perlow JH. Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient population in Phoenix and Yuma, AZ. Am J Obstet Gynecol. 2001;184(6):1263-1266.
24. Canfield MA, Anderson JL, Waller DK, Palmer SE, Kaye CI. Folic acid awareness and use among women with a history of neural tube defect pregnancy - Texas, 2000-2001. MMWR Recomm Rep. 2002:51(RR13):16-19.
25. Chacko MR, Anding R, Kozinetz CA, Glover JL, Smith PB. Neural tube defects: knowledge and preconceptional practices in minority women. Pediatrics. 2003;112(3, pt 1):536-542.
26. Ford E, Bowman B. Serum and red blood cell folate concentrations, race, and education: findings from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 1999;69:476.
27. O'Rourke K, Redlinger T. Postpartum supplemental vitamin use among Hispanic women on the US/Mexico border: need for community health education. Int Q Community Health Educ. 2000;19:33-41.
28. O'Rourke K, Redlinger T, Waller K. Declining levels of erythrocyte folate during the postpartum period among Hispanic women living on the Texas-Mexico. J Womens Health Gender Based Med. 2000;9(4):397-403.
29. Viteri FE. Iron supplementation for the control of iron deficiency in populations at risk. Nutr Rev. 1997;55(6):195-209.
30. Smits L, Essed G. Short interpregnancy intervals and unfavorable pregnancy outcome: role of folate depletion. Lancet. 2001;358:2074-2077.
31. Williams LM, Morrow B, Lansky A, et al. Surveillance for selected maternal behaviors and experiences, before, during, and after pregnancy. MMWR Surveill Summ. 2003;52(SS11):1-14.
32. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons Inc; 2000.
33. Texas Department of Health. Texas birth data 2002. Available at: soupfin.tdh.state.tx.us. Accessed on: 9/1/2004.
34. American Academy of Pediatrics. Guidelines for Perinatal Care. 5th ed. Washington, DC: American College of Obstetricians and Gynecology; 2002.
35. Glover DD, Amonkar N, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural obstetric population. Am J Obstet Gynecol. 2003;188(4):1039-1045.
36. Splinter MY, Sagraves R, Nightengale B, Rayburn WF. Prenatal use of medications by women giving birth at a university hospital. South Med J. 1997;90(5):498-502.
37. Taren DL, Grave SN. The association of prenatal nutrition and educational services with low birth weight rates in a Florida program. Public Health Rep. 1991;106(4):426-437.
38. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol. 1997;15(1):148-156.
39. Power ML, Holzman GB, Schulkin J. Knowledge and clinical practice regarding folic acid among obstetricians-gynecologists. Obstet Gynecol. 2000;95(6):895-898.
40. Ovist I, Abdulla M, Jagerstad M, Svensson S. Iron, zinc, and folate status during pregnancy and two months after delivery. Acta Obstet Gynecol Scand. 1986;65:15-22.
41. Smith AM, Picciano MF, Deering RH. Folate supplementation during lactation: maternal folate status, human milk folate content, and their relationship to infant folate status. J Pediatr Gastroenterol Nutr. 1983;2:622-628.
42. Kallen JE. Reexamination of interpregnancy intervals and subsequent birth outcomes: evidence from US linked birth/infant death records. Soc Biol. 1997;44(3-4):205-212.
43. King JC. Risk of maternal nutritional depletion and poor outcomes increases in early and closely spaced pregnancies. J Nutr. 2003;133(5, suppl 2):1732S-1736S.
44. Miller LP, Greenspan B, Dowd JS. The medical database as a tool for improving maternal/infant continuity of care. J Med Syst. 1999;23(3):219-225.
45. Pistella CY, Synkewecz CA. Community postpartum care needs assessment and systems development for low income families. J Health Soc Policy. 1999;11(1):53-64.
46. Weinman ML, Smith PB. US-Mexico-born Hispanic teen mothers: a descriptive study of factors related to postpartum compliance. Hisp J Behav Sci. 1994;16(2):188-194.